Unfolded protein response in cancer: the Physician's perspective

被引:157
作者
Li, Xuemei [3 ,4 ]
Zhang, Kezhong [2 ]
Li, Zihai [1 ]
机构
[1] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA
[2] Wayne State Univ, Dept Microbiol & Immunol, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[3] Univ Connecticut, Sch Med, Leas Fdn Ctr Hematol Disorders & Neag, Farmington, CT 06030 USA
[4] Univ Connecticut, Sch Med, Ctr Comprehens Canc, Farmington, CT 06030 USA
关键词
ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-REGULATED PROTEINS; BOX BINDING PROTEIN-1; HUMAN LUNG-CANCER; PHASE-II TRIAL; ER STRESS; CELL-DEATH; PROTEASOME INHIBITORS; TRANSLATIONAL CONTROL; MESSENGER-RNA;
D O I
10.1186/1756-8722-4-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The unfolded protein response (UPR) is a cascade of intracellular stress signaling events in response to an accumulation of unfolded or misfolded proteins in the lumen of the endoplasmic reticulum ( ER). Cancer cells are often exposed to hypoxia, nutrient starvation, oxidative stress and other metabolic dysregulation that cause ER stress and activation of the UPR. Depending on the duration and degree of ER stress, the UPR can provide either survival signals by activating adaptive and antiapoptotic pathways, or death signals by inducing cell death programs. Sustained induction or repression of UPR pharmacologically may thus have beneficial and therapeutic effects against cancer. In this review, we discuss the basic mechanisms of UPR and highlight the importance of UPR in cancer biology. We also update the UPR-targeted cancer therapeutics currently in clinical trials.
引用
收藏
页数:10
相关论文
共 117 条
[1]  
ALRAWASHDEH FY, EUR J GASTROENTEROL, V22, P1099
[2]  
[Anonymous], INT J CELL BIOL
[3]   Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene. [J].
Bachleitner-Hofmann, T. ;
Sun, M. Y. ;
Chen, C. ;
Zeng, Z. ;
Viale, A. ;
Olshen, A. ;
Christensen, J. G. ;
Rosen, N. ;
Solit, D. B. ;
Weiser, M. R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[4]   Chaperone-Targeting Cytotoxin and Endoplasmic Reticulum Stress-Inducing Drug Synergize to Kill Cancer Cells [J].
Backer, Joseph M. ;
Krivoshein, Arcadius V. ;
Hamby, Carl V. ;
Pizzonia, John ;
Gilbert, Kenneth S. ;
Ray, Yonaton S. ;
Brand, Harrison ;
Paton, Adrienne W. ;
Paton, James C. ;
Backer, Marina V. .
NEOPLASIA, 2009, 11 (11) :1165-U72
[5]   The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future [J].
Banerji, Udai ;
Judson, Ian ;
Workman, Paul .
CURRENT CANCER DRUG TARGETS, 2003, 3 (05) :385-390
[6]   Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells [J].
Banjerdpongchai, Ratana ;
Kongtawelert, Prachya ;
Khantamat, Orawan ;
Srisomsap, Chantragan ;
Chokchaichamnankit, Daranee ;
Subhasitanont, Pantipa ;
Svasti, Jisnuson .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
[7]   Regulation of apoptosis by endoplasmic reticulum pathways [J].
Breckenridge, DG ;
Germain, M ;
Mathai, JP ;
Nguyen, M ;
Shore, GC .
ONCOGENE, 2003, 22 (53) :8608-8618
[8]   Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models [J].
Caldas-Lopes, Eloisi ;
Cerchietti, Leandro ;
Ahn, James H. ;
Clement, Cristina C. ;
Robles, Ana I. ;
Rodina, Anna ;
Moulick, Kamalika ;
Taldone, Tony ;
Gozman, Alexander ;
Guo, Yunke ;
Wu, Nian ;
de Stanchina, Elisa ;
White, Julie ;
Gross, Steven S. ;
Ma, Yuliang ;
Varticovski, Lyuba ;
Melnick, Ari ;
Chiosis, Gabriela .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (20) :8368-8373
[9]   The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis [J].
Carrasco, Daniel R. ;
Sukhdeo, Kumar ;
Protopopova, Marina ;
Sinha, Raktim ;
Enos, Miriam ;
Carrasco, Daniel E. ;
Zheng, Mei ;
Mani, Mala ;
Henderson, Joel ;
Pinkus, Geraldine S. ;
Munshi, Nikhil ;
Horner, James ;
Ivanova, Elena V. ;
Protopopov, Alexei ;
Anderson, Kenneth C. ;
Tonon, Giovanni ;
DePinho, Ronald A. .
CANCER CELL, 2007, 11 (04) :349-360
[10]   Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma [J].
Chauhan, Dharminder ;
Singh, Ajita V. ;
Ciccarelli, Bryan ;
Richardson, Paul G. ;
Palladino, Michael A. ;
Anderson, Kenneth C. .
BLOOD, 2010, 115 (04) :834-845